Crossmark

Oral Arsenic-Containing Qinghuang Powder: A Potential Drug for Myelodysplastic Syndromes

Published Online: 2020-03-07

Published Print: 2022-08

Authors

Ming, Jing

Liu, Wei-yi

Xiao, Hai-yan

Xu, Yong-gang

Ma, Rou

Hu, Xiao-mei
License Information

Text and Data Mining valid from 2020-03-07

Version of Record valid from 2020-03-07
More Information

Article History

Accepted: 17 December 2019

First Online: 7 March 2020

Conflict of Interest

: All authors declare that they have no conflict of interests.

Document is current